Profil de l'entreprise · Healthcare

Doximity Inc

DOCS · États-Unis
Pays / Région
USA
Date d'introduction en bourse
24 juin 2021
Effectif
880
Buffett Score
78/100
Solide
Capitalisation4,98 Md $US
Chiffre d'affaires (TTM)655,57 M $US
EBITDA208,4 M $US
Marge nette25,48 %
ROE17,21 %
PER (TTM)34,06
PER prévisionnel19,76
PEG0,59
BPA0,82 $US
Fourchette sur 52 semaines17,15 $US – 73,92 $US
Objectif de cours des analystes29,67 $US
Recommandation des analystes3.4 / 5

Données EODHD, présentées dans la devise de reporting ; à titre indicatif uniquement, ne constitue pas un conseil en investissement.

Doximity, Inc. operates a digital platform for medical professionals in the United States. Its Doximity platform includes a personalized newsfeed that presents clinical and professional content to members, which offers medical articles, clinical trials or research results in an easy-to-consume video format, professional updates and accomplishments of their peers and colleagues, clinical discussions, Op-Med articles for publication, and sponsored content from pharmaceutical manufacturers and health systems. The company also offers workflow tools, including Ask, a HIPAA-compliant AI assistant, to access and apply evidence-based medical information within clinical workflows; Scribe, a HIPAA-compliant, AI-powered clinical documentation tool; Telehealth tools for hospitals and health systems; and AMiON, an on-call scheduling tool. The company primarily serves physicians, nurse practitioners, physician assistants, medical students, pharmaceutical manufacturers, and healthcare systems. The company was formerly known as 3MD Communications, Inc. and changed its name to Doximity, Inc. in June 2010. Doximity, Inc. was incorporated in 2010 and is headquartered in San Francisco, California.

Historique

Bientôt disponibleCette section est en cours de complétion ; revenez bientôt.

Position dans le secteur

Bientôt disponibleCette section est en cours de complétion ; revenez bientôt.

Pas encore d'analyse sur cette valeur dans votre langue.